Cardiovascular Device Market Size, Share, Trends, Industry Analysis Report: By Device Type, Application, End Use (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics), and Region (North America, Europe, Asia Pacific, Latin America, and Middle Ea

The cardiovascular device market size is expected to reach USD 128.23 billion by 2034, according to a new study by Polaris Market Research. The report “Cardiovascular Device Market Size, Share, Trends, Industry Analysis Report: By Device Type, Application, End Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

A cardiovascular device is a medical instrument used to diagnose, treat, or manage heart-related conditions, such as pacemakers, stents, and defibrillators. Raising awareness about heart diseases is driving the cardiovascular devices market demand. Educational campaigns, government initiatives, and public health efforts have made people more conscious of heart health risks. Increased recognition of the signs and symptoms of heart disease leads individuals to seek early medical intervention. This proactive approach encourages the use of cardiovascular devices such as diagnostic tools, stents, and pacemakers to manage and prevent heart-related conditions. A growing understanding of how lifestyle choices impact heart health motivates more people to use these devices for improved treatment and prevention.

The growing prevalence of lifestyle-related diseases such as obesity, diabetes, and hypertension is a key factor driving the cardiovascular device market growth. These conditions are major risk factors for cardiovascular diseases (CVDs), increasing the demand for devices that aid in diagnosing, managing, and treating heart-related issues. Obesity and physical inactivity contribute significantly to the onset of heart diseases, making devices such as stents, pacemakers, and diagnostic tools essential for managing these conditions. The rising number of individuals developing these lifestyle diseases leads to an increasing need for cardiovascular interventions, further expanding the market for devices targeting heart conditions.

Cardiovascular Device Market Report Highlights

Based on end use, in 2024, the hospital segment dominated the cardiovascular device market share due to the large number of footfall of patients in the hospital settings.

The diagnostics and monitoring device segment, by device type, is expected to witness fastest growth during the forecast period due to rising focus on preventive healthcare.

In 2024, North America dominated the global cardiovascular device market revenue share, due to the presence of a large number of hospitals equipped with advanced medical technologies.

Asia Pacific is expected to record a significant share during the forecast period, driven by an increase in heart disease cases and advancements in healthcare infrastructure.

A few global key market players are Abbott Laboratories; B. Braun Melsungen AG; Biotronik SE & Co.KG; Boston Scientific Corporation; C. R. Bard, Inc.; Cook Medicals; Lepu Medicals; Liaoning Biomedical Materials; Medtronic Plc; Meril Life Sciences; MicroPort Scientific Corporation; Terumo Corporation; Translumina GmbH; Vascular Concepts; Jude Medical, Inc.; and Edward lifesciences corporation.

Polaris Market Research has segmented the cardiovascular device market report on the basis of device type, application, end use, and region:

By Device Type (Revenue – USD Billion, 2020–2034)

§ Diagnostic and Monitoring Devices

• Electrocardiogram
• Remote Cardiac Monitoring
• MRI
• Others

§ Therapeutic and Surgical Devices

• Ventricular Assist Devices
• Cardiac Rhythm Management Devices
• Catheter
• Stents
• Others

By Application (Revenue – USD Billion, 2020–2034)

§ Heart Failure

§ Cardiac Arrhythmia

§ Coronary Artery Disease

§ Others

By End Use (Revenue – USD Billion, 2020–2034)

§ Hospitals

§ Ambulatory Surgical Centers

§ Specialty Clinics

By Regional Outlook (Revenue – USD Billion, 2020–2034)

North America

• US
• Canada

Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Australia
• Rest of Asia Pacific

Latin America

• Argentina
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of Middle East & Africa